New Amsterdam Partners’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-6,500
Closed -$428K – 136
2017
Q1
$428K Sell
6,500
-1,250
-16% -$86K 0.1% 109
2016
Q4
$533K Buy
7,750
+1,737
+29% +$124K 0.12% 103
2016
Q3
$424K Sell
6,013
-56
-0.9% -$4.19K 0.1% 107
2016
Q2
$460K Sell
6,069
-1,059
-15% -$77.9K 0.11% 102
2016
Q1
$490K Sell
7,128
-538
-7% -$38.7K 0.05% 106
2015
Q4
$670K Sell
7,666
-2,480
-24% -$212K 0.07% 103
2015
Q3
$821K Buy
10,146
+23
+0.2% +$2K 0.08% 97
2015
Q2
$900K Sell
10,123
-28,952
-74% -$2.53M 0.08% 94
2015
Q1
$3.39M Buy
39,075
+81
+0.2% +$6.79K 0.27% 89
2014
Q4
$3.3M Sell
38,994
-7,482
-16% -$585K 0.29% 90
2014
Q3
$3.28M Sell
46,476
-38
-0.1% -$2.71K 0.22% 86
2014
Q2
$3.23M Sell
46,514
-20
-0% -$1.41K 0.21% 84
2014
Q1
$3.49M Sell
46,534
-4,844
-9% -$363K 0.24% 67
2013
Q4
$3.61M Sell
51,378
-496
-1% -$32.4K 0.24% 69
2013
Q3
$3.21M Sell
51,874
-210,375
-80% -$13.6M 0.21% 73
2013
Q2
$16.2M Buy
+262,249
New +$15.8M 0.86% 51

Other funds holding ESRX

New Amsterdam Partners's ESRX Position: Q2 2017 in Review

New Amsterdam Partners sold out of Express Scripts Holding Company (ESRX) in Q2 2017, closing a stake of 6,500 shares — an estimated $428K sold.

New Amsterdam Partners first reported a position in ESRX in Q2 2013 and held it in 16 quarters. The position peaked at $16.2M in Q2 2013. 1,046 funds tracked by Wall St. Rank hold ESRX as of Q2 2017.

  • New Amsterdam Partners reported no remaining Express Scripts Holding Company position as of Q2 2017 after selling out during the quarter.
  • New Amsterdam Partners sold 6,500 Express Scripts Holding Company shares in Q2 2017, an estimated $428K.
  • New Amsterdam Partners first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 16 quarters.
  • New Amsterdam Partners's Express Scripts Holding Company position peaked at $16.2M in Q2 2013.
  • 1,046 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2017.

Based on New Amsterdam Partners's 13F filing for Q2 2017, filed 2 Aug 2017.